---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-22-000020"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:47:19.613659+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Prestige Q1 FY2023 revenue $277.1M, EPS $1.09, reaffirms full-year guidance

## Summary
- Revenue $277.1M, +2.9% YoY; organic revenue (ex-Akorn, FX) declined 1.2%.
- Diluted EPS $1.09 vs $1.14 prior year, but ahead of internal expectations.
- Net cash from operations $58.2M; Non-GAAP free cash flow $57.2M.
- Reaffirmed FY2023 guidance: revenue $1.12-1.13B, EPS $4.18-4.23, FCF >=$260M.
- North American OTC flat at $242.5M; International OTC record $34.5M (+28.9%).

## SEC filing metadata
- accession: 0001295947-22-000020
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/0001295947-22-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000020/pbh-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-22-000020
- JSON: https://secwatch.observer/filing/0001295947-22-000020.json
- Plain text: https://secwatch.observer/filing/0001295947-22-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.